Kyle L. Macauslane

Kyle L. Macauslane

Auto-generated profile, based on publicly available information

Kyle L. Macauslane

School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2023 in Critical Reviews in Microbiology
Verified
Journal Article
Closed access
KMKyle L. Macauslane
Kyle L. Macauslane
CPCassandra L. Pegg
Cassandra L. Pegg
Kirsty ShortKirsty Short
Kirsty Short
BSBenjamin Schulz
Benjamin Schulz
Acute respiratory infections (ARIs) are amongst the leading causes of death and disability, and the greatest burden of disease impacts children, pregnant women, and the elderly. Respiratory viruses account for the majority of ARIs. The unfolded protein response (UPR) is a host homeostatic defence mechanism primarily activated in response to aberrant endoplasmic reticulum (ER) resident protein accumulation in cell stresses including viral infection. The UPR has been implicated in the pathogenesis of several respiratory diseases, as the respiratory system is particularly vulnerable to chronic and acute activation of the ER stress response pathway. Many respiratory viruses therefore employ strategies to modulate the UPR during infection, with varying effects on the host and the pathogens. Here, we review the specific means by which respiratory viruses affect the host UPR, particularly in association with the high production of viral glycoproteins, and the impact of UPR activation and subversion on viral replication and disease pathogenesis. We further review the activation of UPR in common co-morbidities of ARIs and discuss the therapeutic potential of modulating the UPR in virally induced respiratory diseases.

30 October 2024 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
JSJane E. Sinclair
Jane E. Sinclair
CVCourtney Vedelago
Courtney Vedelago
FRFeargal Ryan
Feargal Ryan
MCMeagan Carney
Meagan Carney
MRMeredith A. Redd
Meredith A. Redd
Kirsty ShortKirsty Short
Kirsty Short
An estimated 65 million people globally suffer from post-acute sequelae of COVID-19 (PASC), with many experiencing cardiovascular symptoms (PASC-CVS) like chest pain and heart palpitations. This study examines the role of chronic inflammation in PASC-CVS, particularly in individuals with symptoms persisting over a year after infection. Blood samples from three groups—recovered individuals, those with prolonged PASC-CVS and SARS-CoV-2-negative individuals—revealed that those with PASC-CVS had a blood signature linked to inflammation. Trace-level pro-inflammatory cytokines were detected in the plasma from donors with PASC-CVS 18 months post infection using nanotechnology. Importantly, these trace-level cytokines affected the function of primary human cardiomyocytes. Plasma proteomics also demonstrated higher levels of complement and coagulation proteins in the plasma from patients with PASC-CVS. This study highlights chronic inflammation’s role in the symptoms of PASC-CVS.

27 June 2024 in Analytical Chemistry
Verified
Journal Article
Closed access
KMKyle L. Macauslane
Kyle L. Macauslane
CPCassandra L. Pegg
Cassandra L. Pegg
ANAmanda S. Nouwens
Amanda S. Nouwens
EKEdward Kerr
Edward Kerr
JSJoy Seitanidou
Joy Seitanidou
BSBenjamin Schulz
Benjamin Schulz

16 June 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
AIAriel Isaacs
Ariel Isaacs
YLYu Shang Low
Yu Shang Low
KMKyle L. Macauslane
Kyle L. Macauslane
JSJoy Seitanidou
Joy Seitanidou
CPCassandra L. Pegg
Cassandra L. Pegg
DWDaniel Watterson
Daniel Watterson
In August 2022, a novel henipavirus (HNV) named Langya virus (LayV) was isolated from patients with severe pneumonic disease in China. This virus is closely related to Mòjiāng virus (MojV), and both are divergent from the bat-borne HNV members, Nipah (NiV) and Hendra (HeV) viruses. The spillover of LayV is the first instance of a HNV zoonosis to humans outside of NiV and HeV, highlighting the continuing threat this genus poses to human health. In this work, we determine the prefusion structures of MojV and LayV F proteins via cryogenic electron microscopy to 2.66 and 3.37 Å, respectively. We show that despite sequence divergence from NiV, the F proteins adopt an overall similar structure but are antigenically distinct as they do not react to known antibodies or sera. Glycoproteomic analysis revealed that while LayV F is less glycosylated than NiV F, it contains a glycan that shields a site of vulnerability previously identified for NiV. These findings explain the distinct antigenic profile of LayV and MojV F, despite the extent to which they are otherwise structurally similar to NiV. Our results carry implications for broad-spectrum HNV vaccines and therapeutics, and indicate an antigenic, yet not structural, divergence from prototypical HNVs.

5 February 2026 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
MWMeltem Weger
Meltem Weger
DMDaniel Mauvoisin
Daniel Mauvoisin
DHDominic Hoyle
Dominic Hoyle
JWJingkui Wang
Jingkui Wang
EMEva Martin
Eva Martin
FGFrederic Gachon
Frederic Gachon
The liver has a key role in inter-organ communication by secreting most circulating plasma proteins. However, the mechanisms governing hepatic protein secretion remain unclear. Here we show that hepatic protein secretion follows a diurnal rhythm regulated by food intake in humans and mice. Using liver microsomal proteomics, we find that proteins implicated in the early secretory pathway, such as protein glycosylation and folding in the endoplasmic reticulum (ER) and Golgi apparatus, exhibit a rhythmic expression profile, which is abolished in Bmal1- knockout mice. Mechanistically, we show that hepatic glycogenolysis provides substrates for protein N -glycosylation. In mice, perturbing hepatic glycogenolysis with pharmacological or nutritional interventions leads to ER stress and attenuates diurnal protein secretion. We confirm these results in humans, as genetic variants associated with glycogen storage disease and congenital disorders of glycosylation also alter hepatic protein secretion. Overall, our work uncovers hepatic glycogen metabolism as a circadian regulator of protein secretion.

23 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
KMKyle L. Macauslane
Kyle L. Macauslane
CPCassandra L. Pegg
Cassandra L. Pegg
ANAmanda S. Nouwens
Amanda S. Nouwens
EKEdward Kerr
Edward Kerr
JSJoy Seitanidou
Joy Seitanidou
BSBenjamin Schulz
Benjamin Schulz
Tandem mass spectrometry coupled with liquid chromatography (LC-MS/MS) has proven a versatile tool for the identification and quantification of proteins and their post-translational modifications (PTMs). Protein glycosylation is a critical PTM for the stability and biological function of many proteins, but full characterisation of site-specific glycosylation of proteins remains analytically challenging. Collision induced dissociation (CID) is the most common fragmentation method used in LC-MS/MS workflows, but loss of labile modifications render CID inappropriate for detailed characterisation of site-specific glycosylation. Electron-based dissociation (ExD) methods provide alternatives that retain intact glycopeptide fragments for unambiguous site localisation, but these methods often underperform CID due to increased reaction times and reduced efficiency. Electron activated dissociation (EAD) is another strategy for glycopeptide fragmentation. Here, we use a ZenoTOF 7600 SCIEX instrument to compare the performance of various fragmentation techniques for the analysis of a complex mixture of mammalian O - and N -glycopeptides. We found CID fragmentation identified the most glycopeptides and generally produced higher quality spectra, but EAD provided improved confidence in glycosylation site localisation. Supplementing EAD with CID fragmentation (EAciD) further increased the number and quality of glycopeptide identifications, while retaining localisation confidence. These methods will be useful for glycoproteomics workflows for either optimal glycopeptide identification or characterisation.